These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28167242)

  • 1. Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
    Olkhov-Mitsel E; Savio AJ; Kron KJ; Pethe VV; Hermanns T; Fleshner NE; van Rhijn BW; van der Kwast TH; Zlotta AR; Bapat B
    Transl Oncol; 2017 Apr; 10(2):168-177. PubMed ID: 28167242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.
    Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C
    FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.
    Kitchen MO; Bryan RT; Emes RD; Glossop JR; Luscombe C; Cheng KK; Zeegers MP; James ND; Devall AJ; Mein CA; Gommersall L; Fryer AA; Farrell WE
    Epigenetics; 2016 Mar; 11(3):237-46. PubMed ID: 26929985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
    Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
    Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
    Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
    J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
    Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
    Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
    Kitchen MO; Bryan RT; Haworth KE; Emes RD; Luscombe C; Gommersall L; Cheng KK; Zeegers MP; James ND; Devall AJ; Fryer AA; Farrell WE
    PLoS One; 2015; 10(9):e0137003. PubMed ID: 26332997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study.
    García-Baquero R; Puerta P; Beltran M; Alvarez M; Sacristan R; Alvarez-Ossorio JL; Sánchez-Carbayo M
    J Urol; 2013 Aug; 190(2):723-30. PubMed ID: 23485510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated methylated lncRNAs in patients with bladder cancer.
    Zhang S; Cao H; Ye L; Wen X; Wang S; Zheng W; Zhang Y; Huang D; Gao Y; Liu H; He H; Gao X; Chen Y; Chen M; Xiang Y; Wang F
    Am J Transl Res; 2019; 11(6):3790-3800. PubMed ID: 31312389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
    Zuiverloon TC; Beukers W; van der Keur KA; Munoz JR; Bangma CH; Lingsma HF; Eijkemans MJ; Schouten JP; Zwarthoff EC
    BJU Int; 2012 Mar; 109(6):941-8. PubMed ID: 21756281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
    Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
    Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative DNA methylation and gene expression analysis identifies novel genes for structural congenital heart diseases.
    Grunert M; Dorn C; Cui H; Dunkel I; Schulz K; Schoenhals S; Sun W; Berger F; Chen W; Sperling SR
    Cardiovasc Res; 2016 Oct; 112(1):464-77. PubMed ID: 27496870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancer.
    Abat D; Demirhan O; Inandiklioglu N; Tunc E; Erdogan S; Tastemir D; Uslu IN; Tansug Z
    Oncol Lett; 2014 Jul; 8(1):25-32. PubMed ID: 24959214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low- and high-grade bladder cancer appraisal via serum-based proteomics approach.
    Bansal N; Gupta A; Sankhwar SN; Mahdi AA
    Clin Chim Acta; 2014 Sep; 436():97-103. PubMed ID: 24875752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.